Galaxy Gaming, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Galaxy Gaming, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $1.15M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | $1.15M | Apr 1, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.87M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $31.74M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $27.79M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $23.44M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $19.98M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | $10.23M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $21.30M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $18.56M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $14.86M | Apr 1, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $14.86M | Apr 2, 2018 |
| FY2016 | Dec 31, 2016 | $12.45M | Apr 17, 2017 |
| FY2015 | Dec 31, 2015 | $10.95M | Mar 30, 2016 |
| FY2014 | Dec 31, 2014 | $9.85M | Mar 31, 2015 |
| FY2013 | Dec 31, 2013 | $8.22M | Mar 31, 2014 |
| FY2012 | Dec 31, 2012 | $7.22M | Apr 1, 2013 |
| FY2011 | Dec 31, 2011 | $3.68M | Apr 20, 2012 |
| FY2011 | Dec 31, 2010 | $3.05M | Apr 20, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.48M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($2.63M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($1.81M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($1.77M) | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $2.11M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | ($2.21M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $2.94M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.22M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($11.4K) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.77M | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.18M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $5.70M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $6.73M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $6.07M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $4.35M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | ($2.26M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.07M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.91M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.50M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.39M | Apr 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $931.3K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $1.06M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $823.2K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $584.5K | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $520.4K | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | $487.7K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $821.1K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $926.5K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $488.8K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $353.8K | Apr 2, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.23M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $19.69M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $15.68M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $12.55M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $10.65M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | $8.96M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $13.30M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $10.96M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $9.06M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $6.73M | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.70M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $4.10M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $2.73M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $6.39M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $6.47M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | ($1.63M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.89M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $4.29M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.84M | Apr 1, 2019 |
| FY2013 | Dec 31, 2013 | $2.38M | Mar 31, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $122.9K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $56.6K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $15.5K | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $117.0K | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $60.1K | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | $62.8K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $106.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $69.8K | Mar 30, 2020 |
| FY2014 | Dec 31, 2014 | $76.7K | Mar 31, 2015 |
| FY2014 | Dec 31, 2013 | $22.7K | Mar 31, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.50M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $41.01M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $40.48M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $42.01M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $40.45M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | $30.57M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $22.99M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $21.19M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $19.11M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $19.01M | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.97M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $61.07M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $58.72M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $59.90M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $57.74M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | $55.37M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $50.62M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $13.74M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $13.65M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $14.39M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($17.47M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($20.05M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | ($18.24M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | ($17.89M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2021 | ($17.29M) | Mar 25, 2024 |
| FY2022 | Dec 31, 2020 | ($24.80M) | Apr 7, 2023 |
| FY2021 | Dec 31, 2019 | ($27.63M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $7.46M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $5.46M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $4.63M | Apr 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $1.09M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $1.09M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $1.09M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $1.09M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | $1.09M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.09M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.09M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.09M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.09M | Apr 2, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($38.27M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($39.75M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($37.12M) | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | ($35.32M) | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | ($33.54M) | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | ($35.66M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($33.45M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.68M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.47M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.48M | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.31M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $18.12M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $16.69M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $18.24M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $16.06M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | $5.99M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $9.69M | Mar 31, 2021 |
| FY2017 | Dec 31, 2017 | $3.49M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $2.30M | Apr 2, 2018 |
| FY2017 | Dec 31, 2015 | $570.6K | Apr 2, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.28M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $54.96M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $54.05M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | $53.90M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | $53.24M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | $51.91M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $47.93M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $10.11M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $8.58M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $9.87M | Apr 2, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 25.35M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 25.12M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 24.85M | Mar 24, 2025 |
| FY2023 | Dec 31, 2022 | 24.41M | Mar 25, 2024 |
| FY2022 | Dec 31, 2021 | 23.52M | Apr 7, 2023 |
| FY2021 | Dec 31, 2020 | 21.97M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 18.02M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 39.92M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 39.57M | Apr 1, 2019 |
| FY2017 | Sep 22, 2017 | 39.37M | Apr 2, 2018 |